Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP951595priorityCriticalpatent/ECSP951595A/en
Publication of ECSP951595ApublicationCriticalpatent/ECSP951595A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Pyrrole Compounds
(AREA)
Abstract
Se describen los compuestos de pirrol. Estos compuestos son útiles como agentes antinflamatorios en el tratamiento de la inflamación y del dolor. También se describen la preparación de estos compuestos, de sus sales aceptables farmacéuticamente y de las composiciones farmaceuticas que contienen estos compuestos.Pyrrole compounds are described. These compounds are useful as anti-inflammatory agents in the treatment of inflammation and pain. The preparation of these compounds, their pharmaceutically acceptable salts and the pharmaceutical compositions containing these compounds are also described.
ECSP9515951995-11-231995-11-23
DERIVATIVES OF PIRROL CASE RAN 4070/101
ECSP951595A
(en)
PIRAZOLOPIRIDINES, PYRROLOPYRIDIDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCEDURES FOR ITS ADMINISTRATION AS AN ANTAGONIST OF THE CORTICO-TROPINE RELEASE FACTOR
SUBSTANCES LIBRARY CONTAINING BICYCLE IMIDAZO-5-IL-AMINES AND / OR BICYCLIC 3-IL-AMINAS IMMEDITION, PROCEDURE FOR THE PREPARATION OF SUBSTANTIAL LIBRARY, AND USE OF SUBSTANCES OF THIS LIBRARY FOR THE PREPARATION OF DRUG PREPARATION
TRICYCLIC UREA COMPOUNDS USEFUL FOR THE INHIBITION OF THE FUNCTION OF PROTEIN G AND FOR THE TREATMENT OF PROTEOLYTIC DISEASES, PHARMACEUTICAL COMPOSITION, AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES.
2- (2-N-ALCOXIFENIL) -PURIN-6-ONAS 9-SUBSTITUTED, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE TO PREPARE PHARMACEUTICAL COMPOSITIONS.
COMPOUNDS OF 10-AMINOALIFATIL-DIBENZ [B, F] ANTINEURODEGENERATIVELY ACTIVE OXEPINS, USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE STATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM